{"text": "Prevalence\n\nAccording to a study published in the Journal of Clinical Psychopharmacology\n\n(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449441/), EPS occur in\n\napproximately 20-30% of patients taking antipsychotics.\n\nManagement\n\nTo manage EPS, healthcare providers may adjust the dosage or switch to a\n\ndifferent antipsychotic medication. In some cases, medications like benzhexol\n\n(Cogentin) can be used to alleviate symptoms.\n\n2. Metabolic Changes\n\nDefinition", "embedding": []}